Renal denervation for treatment-resistant hypertension

@article{Mafeld2012RenalDF,
  title={Renal denervation for treatment-resistant hypertension},
  author={Sebastian Mafeld and Nikhil Vasdev and Philip J. Haslam},
  journal={Therapeutic Advances in Cardiovascular Disease},
  year={2012},
  volume={6},
  pages={245 - 258}
}
Hypertension is a major public health concern that is increasing in prevalence. Lifestyle and pharmacological management are not always sufficient to control blood pressure and treatment-resistant hypertension is a recognized clinical challenge. Renal sympathetic denervation (RSD) represents a new frontier in the treatment of resistant hypertension. Results from the Symplicity HTN-1 and HTN-2 trials have demonstrated evidence that suggests RSD can safely reduce blood pressure in patients with… Expand
Renal sympathetic denervation for treatment-resistant hypertension
TLDR
Renal sympathetic denervation (RSDN) is a novel treatment for resistant hypertension that aims to decrease the sympathetic nervous systems drive and decrease blood pressure. Expand
Renal Denervation for Treating Resistant Hypertension: Current Evidence and Future Insights from a Global Perspective
TLDR
Questions remain to be answered such as the long-term durability of renalDenervation, the efficacy in patients with other sympathetically mediated diseases, and whether renal denervation would benefit patients with stage 1 hypertension. Expand
Catheter-based renal denervation for treatment of resistant hypertension
TLDR
Reduction of renal sympathetic activity by percutaneous catheter-based radiofrequency ablation via the renal arteries has been shown in several studies to decrease blood pressure in patients with resistant hypertension, and importantly is largely free of significant complications. Expand
[Renal sympathetic denervation in treatment-resistant hypertension].
TLDR
Before RDN can become recommended treatment in Norway, more evidence is required that the method lowers blood pressure, and that this reduces morbidity and mortality. Expand
Resistant hypertension: is renal denervation the current treatment of choice?
  • A. Reddi
  • Medicine
  • Clinical and experimental hypertension
  • 2014
TLDR
This review summarizes the results of the studies of renal denervation for resistant hypertension and suggests the use of this procedure in several other conditions that are associated with SNS overactivity. Expand
Renal denervation and blood pressure reduction in resistant hypertension: a systematic review and meta-analysis
TLDR
While poor quality unblinded studies provide evidence that renal denervation using catheter-based systems is effective in reducing systolic and diastolic blood pressure in resistant hypertension, the largest randomised controlled trial to date (SYMPLICITY HTN-3) failed to demonstrate any benefit. Expand
2019 Consensus Statement of the Taiwan Hypertension Society and the Taiwan Society of Cardiology on Renal Denervation for the Management of Arterial Hypertension.
TLDR
The Task Force considers RDN as a legitimate alternative antihypertensive strategy and recommends RDN should be performed in the context of registry and clinical studies and should not be performed routinely, without detailed evaluation of various causes of secondary hypertension and renal artery anatomy. Expand
Effects of Renal Denervation on Sympathetic Nervous System Activity
TLDR
The rapid evolution in the understanding of both the human renal nerve microanatomy and the ideal technique for the safe application of radiofrequency technology leads to successful renal nerve ablation in previous trials on resistant hypertension and for future studies in pathophysiological conditions characterized by an hyperadrenergic tone. Expand
Considerations in Women with Hypertension
TLDR
Pregnancy and menopause present unique, complex challenges in hypertension management, and some data comparing hypertensive women to age-matched men suggest advantages to sex-specific strategies, but further study is needed to determine optimal regimens for women throughout their lives. Expand
Renal artery nerve distribution and density in the porcine model: biologic implications for the development of radiofrequency ablation therapies.
TLDR
In the porcine model, renal artery nerves are seen more frequently in the proximal segment of the artery, and nerve size distribution appears to be homogeneous throughout the artery length. Expand
...
1
2
...

References

SHOWING 1-10 OF 156 REFERENCES
Renal denervation for hypertension.
TLDR
The following review provides an overview of the anatomy and physiology of the renal S NS, the rational for manipulating the SNS, and the results of therapeutic renal sympathetic denervation. Expand
Renal sympathetic denervation and systemic hypertension.
TLDR
The pathophysiology of kidney function justifies the use of RSD in the treatment of hypertension, and the past and the present of this interventional approach are described, and several future potential applications are considered. Expand
[Renal sympathetic denervation for treatment of resistant hypertension].
TLDR
The authors describe two cases of radiofrequency renal sympathetic denervation that illustrate the feasibility of this new technique for the treatment of resistant hypertension. Expand
Renal Denervation in the Treatment of Hypertension
TLDR
Catheter-based renal sympathetic denervation is a novel therapeutic technique for the treatment of resistant hypertension that has the potential to provide benefit in a variety of diseases, but these concepts have to be evaluated in well-designed prospective controlled clinical trials. Expand
Characterization and treatment of resistant hypertension
Resistant hypertension is a common medical problem. It carries a significantly increased risk of end-organ damage and cardiovascular events compared with more easily controlled hypertension.Expand
Renal sympathetic denervation as second‐line therapy in mild resistant hypertension: A pilot study
TLDR
This study sought to investigate the feasibility, safety, and effectiveness of CRD in patients with longstanding mild hypertension despite treatment with ≥ 3 antihypertensive drugs. Expand
Renal sympathetic denervation in resistant hypertension.
TLDR
Renal sympathetic percutaneous denervation is an endovascular procedure that uses radiofrequency energy to destroy the autonomic renal nerves running inside the adventitia of renal arteries and represents a promising new approach to the strategy of inhibiting the sympathetic nervous system. Expand
Renal denervation: time to open Pandora's box.
TLDR
Renal denervation should only be offered within a clinical research context at highly skilled tertiary referral centres that participate in international registries constructed independent of the manufacturers. Expand
Renal Artery Denervation for the Treatment of Hypertension: Opening up New Horizons
TLDR
Renal denervation has been used successfully as atherapeutic strategy to prevent hypertension in a variety ofexperimental models and a new interventional procedure, catheter-based renal sympathetic denervation (RSD), promises help in cases of resistant hypertension. Expand
Renal sympathetic denervation: the jury is still out
The Symplicity HTN-2 Investigators deserve credit for building on the proof-of-principle study, and for addressing a substantial concern (the need for a randomised trial) by undertaking the fi rstExpand
...
1
2
3
4
5
...